Recovery coefficient. by Masakazu Tsujimoto (22339504)

Results of dose linearity. by Masakazu Tsujimoto (22339504)

Expression of cytokines by CD3+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

Expression of cytokines by CD8+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

Effect of MF (2 mT, 50 Hz) on ERK activation and phosphorylation levels of HUVECs. by Simona Delle Monache (402973)

Quantification of intratumoral CD3+ and CD8+ lymphocytes. by Gerik W. Tushoski-Alemán (17951809)

Lipolytic treatment decreased cellular neutral lipids and increased extracellular fatty acids and glycerol. by Caroline Louis (332423)

“…<p>At day 11, differentiated rat adipocytes, which were previously contaminated with PCBs, were incubated with a lipolytic medium supplemented with 1 µM isoproterenol. We renewed the lipolytic medium every 3 hours for 12 hours. …”

Assessment of intratumoral CD3+ and CD8+ lymphocyte populations. by Gerik W. Tushoski-Alemán (17951809)

Loss of <i>Nf1</i> increases sleep fragmentation and decreases sleep depth. by Elizabeth B. Brown (4582978)

“…<b>A</b>. There is a significant effect of genotype on sleep duration (two-way ANOVA: F_2,172 = 80.70, <i>P</i><0.0001). …”

Muscle quality, but not muscle thickness, is decreased in different age groups of active older women by Pedro Lopez (4530202)

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

ILK and talin mediate DZ-50 action on prostate cancer cell death and migration. by Patrick J. Hensley (518001)

“…On the left, DU-145 cells in which talin has been silence (shTalin) or overexpressed (Talin+), exhibit significant reduction or marked overexpression of talin protein levels respectively, relative to parental DU-145 cells. Panel B, DZ-50 treatment leads to a significant decrease in prostate cancer cell viability in a time-dependent fashion. …”

Scatterplot and line plot of predicted response for the 25^th, 50^th and 75th quantile for MCS in nonseminomas cases, on time between diagnosis and compilation... by Aleksandar Jovanovski (11529711)

Scatterplot and line plot of predicted response for the 25^th, 50^th and 75th quantile for PCS in nonseminomas cases, on time between diagnosis and compilation... by Aleksandar Jovanovski (11529711)

The key mechanical parameters of sprint as a function of speed. by Patrícia Dias Pantoja (5824004)

Potent 5‑Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1–UBE2M Interaction by Wenjuan Zhou (115285)

“…After finding a novel inhibitor <b>DC-1</b> with IC₅₀ = 1.2 μM, we performed a series of chemical optimizations, which finally led to the discovery of a potent thiazole containing 5-cyano-6-phenylpyrimidin-based inhibitor <b>DC-2</b> (IC₅₀ = 15 nM). …”

Identification of a Novel Protein Phosphatase 2A Activator, PPA24, as a Potential Therapeutic for FOLFOX-Resistant Colorectal Cancer by Hannah Johnson (1342596)

“…<b>PPA24</b> (<b>19a</b>) was identified as the most cytotoxic compound with IC₅₀ values in the range of 2.36–6.75 μM in CRC and FOLFOX-resistant CRC cell lines. …”

Effect of withanone and withaferin A purified from WSWE on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

ANOM analysis of evaluated criteria K1–K5. by Roman Vavrek (13200141)

“…The presented research works with five criteria, identified by the Institute for Economic and Social Reforms, and aims to quantify the agreement of the results of the assessment of the financial health of territorial self-government entities in 2020 using the TOPSIS technique with a gradually decreasing number of criteria. …”

Pull down assay of RhoA. by Frank Roloff (695802)

“…Molecular weight of stained protein bands corresponds to about 20 kDa as reported for RhoA. (B) Relative RhoA level was decreased to approximately 50% of control after Ibuprofen treatment whereas RhoA level after LPA treatment was increased to 200% of control. …”